EyePoint Pharmaceuticals Ownership | Who Owns EyePoint Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

EyePoint Pharmaceuticals Ownership Summary


EyePoint Pharmaceuticals is owned by 136.19% institutional investors, 1.16% insiders. Cormorant asset management, lp is the largest institutional shareholder, holding 15.29% of EYPT shares. Federated Hermes Kaufmann R is the top mutual fund, with 2.99% of its assets in EyePoint Pharmaceuticals shares.

EYPT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEyePoint Pharmaceuticals136.19%1.16%-37.35%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Cormorant asset management, lp8.32M15.29%$62.02M
Suvretta capital management6.78M12.46%$50.53M
Adage capital partners gp5.75M10.56%$42.84M
Blackrock funding, inc. /de5.28M9.70%$39.35M
Franklin resources4.14M7.60%$30.82M
Blackrock3.76M7.12%$32.75M
Vanguard group3.80M6.98%$28.33M
Federated hermes3.71M6.81%$27.62M
Tcg crossover management3.57M6.56%$26.61M
Ra capital management3.18M5.84%$23.70M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Patient square capital lp1.41M3.93%$10.51M
Cormorant asset management, lp8.32M3.41%$62.02M
Tcg crossover management3.57M2.60%$26.61M
Ally bridge group (ny)348.00K2.22%$2.59M
Essex woodlands management1.17M2.01%$8.72M
5am venture management1.05M1.87%$7.82M
Suvretta capital management6.78M1.72%$50.53M
Blue owl capital lp667.59K1.15%$4.97M
Stempoint capital lp579.50K1.08%$4.32M
Artia global partners lp216.70K0.58%$1.61M

Top Buyers

HolderShares% AssetsChange
Ra capital management3.18M0.32%3.18M
Tcg crossover management3.57M2.60%2.65M
Adage capital partners gp5.75M0.07%1.96M
Federated hermes3.71M0.06%1.78M
Suvretta capital management6.78M1.72%1.61M

Top Sellers

HolderShares% AssetsChange
Octagon capital advisors lp---1.09M
T. rowe price investment management206.94K0.00%-1.06M
Deerfield management company, l.p. (series c)---877.79K
Fiera capital---677.04K
First turn management---585.45K

New Positions

HolderShares% AssetsChangeValue
Ra capital management3.18M0.32%3.18M$23.70M
Blue owl capital lp667.59K1.15%667.59K$4.97M
Nantahala capital management600.00K0.19%600.00K$4.47M
Stempoint capital lp579.50K1.08%579.50K$4.32M
Ally bridge group (ny)348.00K2.22%348.00K$2.59M

Sold Out

HolderChange
Assetmark-15.00
Continuum advisory-16.00
Park place capital-23.00
Russell investments group-24.00
Principal securities-24.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241482.78%74,156,37726.76%1361.18%9541.79%24-52.00%
Sep 30, 2024143-8.92%58,500,9580.17%1070.88%68-26.09%489.09%
Jun 30, 2024157-10.29%58,402,7906.20%1101.02%92-21.37%4418.92%
Mar 31, 202417512.90%54,991,98111.00%1030.75%11725.81%375.71%
Dec 31, 202315542.20%49,541,99847.02%1171.52%9345.31%3575.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Federated Hermes Kaufmann R2.04M2.99%986.65K
Federated Hermes Kaufmann Growth2.04M2.99%986.65K
Vanguard Total Stock Mkt Idx Inv1.99M2.89%-
Franklin Biotechnology Discv A(acc)USD1.77M2.58%-
iShares Russell 2000 ETF1.73M2.52%-15.02K
Federated Hermes Kaufmann Small Cap Grow1.61M2.36%769.52K
Federated Hermes Kaufmann Small Cap A1.61M2.36%769.52K
Vanguard US Total Market Shares ETF1.56M2.27%-
Franklin US Small Cap Growth Equity1.18M1.73%-
Franklin Small Cap Growth Adv1.18M1.72%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 20, 2024DICICCO WENDY F-Buy$20.00K
Aug 21, 2024ANDO GORAN-Buy$39.75K
Aug 19, 2024Zaderej Karen L.-Buy$99.75K
Aug 16, 2024Lurker Nancy-Buy$25.00K
Jul 12, 2024GUYER DAVID R-Sell$117.00K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q341
2024 Q242
2024 Q1225
2023 Q41810

EYPT Ownership FAQ


Who Owns EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals shareholders are primarily institutional investors at 136.19%, followed by 1.16% insiders and -37.35% retail investors. The average institutional ownership in EyePoint Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which EyePoint Pharmaceuticals exceeds.

Who owns the most shares of EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals’s largest shareholders are Cormorant asset management, lp (8.32M shares, 15.29%), Suvretta capital management (6.78M shares, 12.46%), and Adage capital partners gp (5.75M shares, 10.56%). Together, they hold 38.31% of EyePoint Pharmaceuticals’s total shares outstanding.

Does Blackrock own EyePoint Pharmaceuticals?

Yes, BlackRock owns 7.12% of EyePoint Pharmaceuticals, totaling 3.76M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 32.75M$. In the last quarter, BlackRock increased its holdings by 977.52K shares, a 35.07% change.

Who is EyePoint Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Patient square capital lp is EyePoint Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 3.93% of its assets in 1.41M EyePoint Pharmaceuticals shares, valued at 10.51M$.

Who is the top mutual fund holder of EyePoint Pharmaceuticals shares?

Federated Hermes Kaufmann R is the top mutual fund holder of EyePoint Pharmaceuticals shares, with 2.99% of its total shares outstanding invested in 2.04M EyePoint Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools